175 related articles for article (PubMed ID: 20635923)
1. The 3rd International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): meeting highlights. 11-13 November, 2009, Dublin, Ireland.
Umansky V
Immunotherapy; 2010 Mar; 2(2):151-4. PubMed ID: 20635923
[TBL] [Abstract][Full Text] [Related]
2. Third International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD 2009).
Kyte JA
Expert Rev Vaccines; 2010 Feb; 9(2):119-23. PubMed ID: 20109021
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
[TBL] [Abstract][Full Text] [Related]
4. Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007.
Schirrmacher V; Beckhove P; Fournier P; Umansky V
Cancer Immunol Immunother; 2008 Sep; 57(9):1421-7. PubMed ID: 18270701
[No Abstract] [Full Text] [Related]
5. Immunostimulatory DNA sequences and cancer therapy.
Weiner GJ
Springer Semin Immunopathol; 2000; 22(1-2):107-16. PubMed ID: 10944805
[No Abstract] [Full Text] [Related]
6. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
Seremet T; Brasseur F; Coulie PG
Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
8. DNA vaccines for cancer.
Shaw DR; Strong TV
Front Biosci; 2006 Jan; 11():1189-98. PubMed ID: 16146806
[TBL] [Abstract][Full Text] [Related]
9. CpG DNA in cancer immunotherapy.
Weiner GJ
Curr Top Microbiol Immunol; 2000; 247():157-70. PubMed ID: 10689786
[No Abstract] [Full Text] [Related]
10. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
11. Genetic vaccination for the active immunotherapy of cancer.
Bronte V
Curr Gene Ther; 2001 May; 1(1):53-100. PubMed ID: 12109138
[TBL] [Abstract][Full Text] [Related]
12. How much help does a vaccine-induced T-cell response need?
Weber JS; Mulé JJ
J Clin Invest; 2001 Mar; 107(5):553-4. PubMed ID: 11238555
[No Abstract] [Full Text] [Related]
13. Peptide-based vaccines for cancer therapy.
Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
[TBL] [Abstract][Full Text] [Related]
14. What's new in the field of cancer vaccines?
Renno T; Lebecque S; Renard N; Saeland S; Vicari A
Cell Mol Life Sci; 2003 Jul; 60(7):1296-310. PubMed ID: 12943219
[TBL] [Abstract][Full Text] [Related]
15. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
[TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy: moving forward with peptide T cell vaccines.
Kumai T; Fan A; Harabuchi Y; Celis E
Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
[TBL] [Abstract][Full Text] [Related]
17. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
18. HER-2/neu as a target for cancer vaccines.
Baxevanis CN; Voutsas IF; Gritzapis AD; Perez SA; Papamichail M
Immunotherapy; 2010 Mar; 2(2):213-26. PubMed ID: 20635929
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines for non-infectious diseases: new treatments for tumour and allergy.
Leitner WW; Thalhamer J
Expert Opin Biol Ther; 2003 Jul; 3(4):627-38. PubMed ID: 12831367
[TBL] [Abstract][Full Text] [Related]
20. Cancer vaccines. Any future?
Myc LA; Gamian A; Myc A
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):249-59. PubMed ID: 21644030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
